In France, the adult population living with diabetes in 2016 is estimated at more than 3.3 million patients treated. Type 1 diabetes (T1DM) represents 5.6% of diabetic patients (approximately 185,000 patients). Numerous studies show that patients fear hypoglycemia, with an impact on their quality of life, sleep disorders and depressive symptoms. In addition, there is a metabolic impact with a problem of therapeutic compliance and an alteration of glycemic control. This study examine the relation between Post Traumatic Stress disorder (PTSD) and diabetes diagnosis or severe hypoglycaemia in adults with Type 1 Diabetes. The aim of this study is to evaluate the prevalence of PTSD in this population.
Study Type
OBSERVATIONAL
Enrollment
297
PCL-S and HADS questionnaires
Hopital Saint Joseph
Marseille, France
Centre Hospitalier de Martigues
Martigues, France
To evaluate the prevalence of post-traumatic stress disorder (PTSD) in adult with Type 1 Diabetes
Score (\>44) measured on the Posttraumatic Stress Disorder Checklist Scale (PCL-S) for severe hypoglycemia
Time frame: baseline
To evaluate the prevalence of post-traumatic stress disorder (PTSD). This PTSD is related to diabetes diagnosis and its initial management.
Score (\>44) measured on the Posttraumatic Stress Disorder Checklist Scale (PCL-S). The patient will complete the questionnaire once to evaluate PTSD related to both diabete diagnosis and its initial management.
Time frame: baseline
To evaluate the prevalence of post-traumatic stress disorder (PTSD) related to severe hypoglycemia.
Score (\>44) measured on the Posttraumatic Stress Disorder Checklist Scale (PCL-S) for severe hypoglycemia
Time frame: baseline
To evaluate the prevalence of post-traumatic stress disorder (PTSD). This PTSD is related to at least one of the following reasons : - severe hypoglycemia - diabetes diagnosis and its initial management.
Score (\>44) measured on the Posttraumatic Stress Disorder Checklist Scale (PCL-S). The patient will complete the questionnaire once to evaluate PTSD related to severe hypoglycemia and/or diabetes diagnosis and its initial management
Time frame: baseline
To evaluate the prevalence of anxiety-depressive disorder in adults with type 1 diabetes
Score (from 0 to 42 ) measured on the Hospital Anxiety and Depression Scale (HADS) Total scores can be categorized into five levels: * HADS score of 7 or less = no symptoms, * HADS score of 8 to 10 = doubtful symptomatology, * HADS score of 11 or more = definite symptomatology.
Time frame: baseline
To demonstrate the presence of anxiety-depressive disorder related to PTSD
Rate of patients with anxiety depressive disorder associated with PTSD
Time frame: baseline
To evaluate whether there is a correlation between PTSD and the patient participation to a therapeutic education program
Percentage of patients with PTSD (PCL-S \> 44) between groups of patients participating or not in a therapeutic education program (Functional Insulin Therapy or multidisciplinary education in day hospital or hospitalization)
Time frame: baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.